Bank Of America Corp Revance Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 179,951 shares of RVNC stock, worth $462,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares

179,951

Previous 504,676 64.34%

Holding current value

$462,474

Previous $2.48 Million 81.39%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $759,856 - $1.54 Million	-324,725 Reduced 64.34%	179,951 $462,000
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $1.38 Million - $2.76 Million	296,003 Added 141.85%	504,676 $2.48 Million
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $426,878 - $822,897	-73,473 Reduced 26.04%	208,673 $1.83 Million
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $193,993 - $295,388	-7,854 Reduced 2.71%	282,146 $7.14 Million
Q1 2023 May 12, 2023	BUY	$18.36 - $35.27 $2.09 Million - $4.02 Million	114,091 Added 64.86%	290,000 $9.34 Million
Q4 2022 Feb 10, 2023	SELL	$18.32 - $30.66 $4.65 Million - $7.77 Million	-253,562 Reduced 59.04%	175,909 $3.25 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $4.65 Million - $9.24 Million	324,549 Added 309.32%	429,471 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$11.52 - $20.4 $807,091 - $1.43 Million	70,060 Added 200.96%	104,922 $1.45 Million
Q1 2022 May 16, 2022	SELL	$12.36 - $20.31 $947,703 - $1.56 Million	-76,675 Reduced 68.74%	34,862 $680,000
Q4 2021 Feb 08, 2022	BUY	$12.46 - $27.87 $511,071 - $1.14 Million	41,017 Added 58.16%	111,537 $1.82 Million
Q3 2021 Nov 15, 2021	BUY	$25.78 - $33.21 $30,807 - $39,685	1,195 Added 1.72%	70,520 $1.97 Million
Q2 2021 Sep 13, 2021	BUY	$26.8 - $31.84 $1.86 Million - $2.21 Million	69,325 New	69,325 $2.06 Million

Others Institutions Holding RVNC

# of Institutions

196

Shares Held

81.5M

Call Options Held

490K

Put Options Held

128K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Revance Therapeutics, Inc. Transaction History